Sign in
4

Changes in Ownership

Pelthos Therapeutics Inc. Filed Acc 0001919246-26-000054

Director sold 558 shares at an average $20.92 ($11,671)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Friedberg Ezra M · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-04-02 Sale : show line 1 in the form 10b5-1 −293 $20.51 $6,010 82,292 D
2026-04-02 Sale : show line 2 in the form 10b5-1 −265 $21.36 $5,661 82,027 D
Open-market sales · 558 sh · avg $20.92 · $11,671
Loading xslF345X06/wk-form4_1775509382.xml…